Effect of L-homocysteine on endothelial cell-cell junctions following F-actin stabilization through tropomyosin-1 overexpression

International Journal of Molecular Medicine

Volumn 32, Issue 1, 2013, Pages 115-129

  Gagat, Maciej ^a   Grzanka, Dariusz ^a   Izdebska, Magdalena ^a   Grzanka, Alina ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

catenin; Cell cell junctions; Filamentous actin cytoskeleton; Zonula occludens 1

Indexed keywords

ALPHA CATENIN; ALPHA TROPOMYOSIN; BETA CATENIN; F ACTIN; HOMOCYSTEINE THIOLACTONE; PROTEIN ZO1;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN STABILITY;

ACTINS; ALPHA CATENIN; CELL DEATH; CELL MOVEMENT; ENDOTHELIAL CELLS; GENE EXPRESSION; HOMOCYSTEINE; HUMANS; INTERCELLULAR JUNCTIONS; TROPOMYOSIN; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84878240416     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1357     Document Type: Article

References (57)

1. Pollard TD: Cytoskeletal functions of cytoplasmic contractile proteins. J Supramol Struct 5: 317-334, 1976.
2. Clarke M and Spudich JA: Nonmuscle contractile proteins: the role of actin and myosin in cell motility and shape determination. Annu Rev Biochem 46: 797-822, 1977.
3. Stossel TP: Contractile proteins in cell structure and function. Annu Rev Med 29: 427-457, 1978.
4. Stricker J, Falzone T and Gardel ML: Mechanics of the F-actin cytoskeleton. J Biomech 43: 9-14, 2010.
5. Zhang J, Betson M, Erasmus J, Zeikos K, Bailly M, Cramer LP and Braga VM: Actin at cell-cell junctions is composed of two dynamic and functional populations. J Cell Sci 118: 5549-5562, 2005.
6. Homeister JW and Willis MS: Atherosclerosis: Pathogenesis, Genetics and Experimental Models. In: Encyclopedia of Life Sciences 2010. John Wiley & Sons Ltd., Chichester, 2010.
7. Boushey CJ, Beresford SA, Omenn GS and Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057, 1995.
8. Nygård O, Vollset SE, Refsum H et al: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274: 1526-1533, 1995.
9. Ueland PM, Refsum H, Beresford SA and Vollset SE: The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72: 324-332, 2000. (Pubitemid 30623491)
10. Tehlivets O: Homocysteine as a risk factor for atherosclerosis: is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism? J Lipids 2011: 702853, 2011.
11. McDowell IF and Lang D: Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J Nutr 130: 369S-372S, 2000.
12. Heydrick SJ, Weiss N, Thomas SR, Cap AP, Pimentel DR, Loscalzo J and Keaney JF Jr: L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med 36: 632-640, 2004. (Pubitemid 38230179)
13. Dejana E: Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5: 261-270, 2004.
14. Hoelzle MK and Svitkina T: The cytoskeletal mechanisms of cell-cell junction formation in endothelial cells. Mol Biol Cell 23: 310-323, 2012.
15. Bazzoni G, Martínez Estrada O and Dejana E: Molecular structure and functional role of vascular tight junctions. Trends Cardiovasc Med 9: 147-152, 1999.
16. Braga VM: Cell-cell adhesion and signalling. Curr Opin Cell Biol 14: 546-556, 2002.
17. Matter K and Balda MS: Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4: 225-236, 2003. (Pubitemid 36288044)
18. Wheelock MJ and Johnson KR: Cadherin-mediated cellular signaling. Curr Opin Cell Biol 15: 509-514, 2003. (Pubitemid 37176958)
19. Harris ES and Nelson WJ: VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 22: 651-658, 2010.
20. Harris TJ and Tepass U: Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol 11: 502-514, 2010.
21. Yonemura S: Cadherin-actin interactions at adherens junctions. Curr Opin Cell Biol 23: 515-522, 2011.
22. Nwariaku FE, Liu Z, Zhu X et al: NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 104: 3214-3220, 2004. (Pubitemid 39507137)
23. Kinumi T, Ogawa Y, Kimata J, Saito Y, Yoshida Y and Niki E: Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic Res 39: 1335-1344, 2005. (Pubitemid 43023798)
24. Xu Y, Arai H, Murayama T, Kita T and Yokode M: Hypercholesterolemia contributes to the development of atherosclerosis and vascular remodeling by recruiting bone marrow-derived cells in cuff-induced vascular injury. Biochem Biophys Res Commun 363: 782-787, 2007. (Pubitemid 47513697)
25. Javanmard SH and Dana N: The effect of interferon γ on endothelial cell nitric oxide production and apoptosis. Adv Biomed Res 1: 69, 2012.
26. Bouïs D, Hospers GA, Meijer C, Molema G and Mulder NH: Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4: 91-102, 2001. (Pubitemid 34032695)
27. Edgell CJ, Reisner HM and Graham JB: Endothelial cell hybrids and the suspension of factor VIII related antigen expression. Br J Haematol 46: 613-620, 1980. (Pubitemid 11242904)
28. Edgell CJ, Haizlip JE, Bagnell CR, Packenham JP, Harrison P, Wilbourn B and Madden VJ: Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol 26: 1167-1172, 1990.
29. Claise C, Chalas J, Edeas M, Abella A, Khalfoun Y, Laurent D and Lindenbaum A: Comparison of oxidized low-density lipoprotein toxicity on EA.hy 926 cells and human vein endothelial cells: influence of antioxidant systems. Cell Mol Life Sci 53: 156-161, 1997. (Pubitemid 27365887)
30. Vrekoussis T, Stathopoulos EN, De Giorgi U et al: Modulation of vascular endothelium by imatinib: a study on the EA.hy 926 endothelial cell line. J Chemother 18: 56-65, 2006.
31. Rosenkranz AC, Lob H, Breitenbach T, Berkels R and Roesen R: Endothelial antioxidant actions of dihydropyridines and angiotensin converting enzyme inhibitors. Eur J Pharmacol 529: 55-62, 2006. (Pubitemid 43005285)
32. Pittenger MF, Kazzaz JA and Helfman DM: Functional properties of non-muscle tropomyosin isoforms. Curr Opin Cell Biol 6: 96-104, 1994. (Pubitemid 24048701)
33. Perry SV: Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil 22: 5-49, 2001.
34. Cooper JA. Actin dynamics: tropomyosin provides stability. Curr Biol 12: R523-R525, 2002. (Pubitemid 34869871)
35. Gunning PW, Schevzov G, Kee AJ and Hardeman EC: Tropomyosin isoforms: divining rods for actin cytoskeleton function. Trends Cell Biol 15: 333-341, 2005. (Pubitemid 40805330)
36. Lin JJ, Eppinga RD, Warren KS and McCrae KR: Human tropomyosin isoforms in the regulation of cytoskeleton functions. Adv Exp Med Biol 644: 201-222, 2008.
37. Plazar N and Jurdana M: Hyperhomocysteinemia: relation to cardiovascular disease and venous thromboembolism. In: Pathophysiology and Clinical Aspects of Venous Thromboembolism in Neonates, Renal Disease and Cancer Patients. Abdelaal MA (ed.). InTech, Rijeka, pp17-34, 2012.
38. Ridker PM, Manson JE, Buring JE, Shih J, Matias M and Hennekens CH: Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 281: 1817-1821, 1999.
39. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr and Loscalzo J: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272: 17012-17017, 1997. (Pubitemid 27289806)
40. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Toyokawa T and Nakashima Y: Homocysteine inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 281: 726-731, 2001. (Pubitemid 32917861)
41. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ and Kitajima S: Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276: 35867-35874, 2001.
42. Lee SJ, Kim KM, Namkoong S et al: Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 280: 5781-5788, 2005.
43. Suhara T, Fukuo K, Yasuda O et al: Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension 43: 1208-1213, 2004. (Pubitemid 38696913)
44. Mercié P, Garnier O, Lascoste L et al: Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 5: 403-411, 2000. (Pubitemid 32162622)
45. Rodríguez-Nieto S, Chavarría T, Martínez-Poveda B, Sánchez-Jiménez F, Rodríguez Quesada A and Medina MA: Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun 293: 497-500, 2002. (Pubitemid 34694235)
46. Wejksza K, Rzeski W and Turski WA: Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells. Pharmacol Rep 61: 751-756, 2009.
47. Vincent PA, Xiao K, Buckley KM and Kowalczyk AP: VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol 286: C987-C997, 2004. (Pubitemid 38506914)
48. Drees F, Pokutta S, Yamada S, Nelson WJ and Weis WI: α-catenin is a molecular switch that binds E-cadherin-β catenin and regulates actin-filament assembly. Cell 123: 903-915, 2005. (Pubitemid 41721035)
49. Yamada S, Pokutta S, Drees F, Weis WI and Nelson WJ: Deconstructing the cadherin-catenin-actin complex. Cell 123: 889-901, 2005. (Pubitemid 41721034)
50. Millán J, Cain RJ, Reglero-Real N et al: Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol 8: 11, 2010.
51. Fanning AS, Ma TY and Anderson JM: Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB 16: 1835-1837, 2002.
52. Itoh M, Nagafuchi A, Moroi S and Tsukita S: Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 138: 181-192, 1997. (Pubitemid 27337462)
53. Fanning AS, Jameson BJ, Jesaitis LA and Anderson JM: The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton J Biol Chem 273: 29745-29753, 1998. (Pubitemid 28509986)
54. Wittchen ES, Haskins J and Stevenson BR: Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 274: 35179-35185, 1999. (Pubitemid 129509574)
55. Van Itallie CM, Fanning AS, Bridges A and Anderson JM: ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 20: 3930-3940, 2009.
56. Chen VC, Li X, Perreault H and Nagy JI: Interaction of zonula occludens-1 (ZO-1) with alpha-actinin-4: application of functional proteomics for identification of PDZ domain-associated proteins. J Proteome Res 5: 2123-2134, 2006. (Pubitemid 44330804)
57. Etournay R, Zwaenepoel I, Perfettini I, Legrain P, Petit C and El-Amraoui A: Shroom2, a myosin-VIIa- and actin-binding protein, directly interacts with ZO-1 at tight junctions J Cell Sci 120: 2838-2850, 2007. (Pubitemid 47394258)